Search
for
Sort by
Research 301–330 of 1000+
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Overlapping of DRESS and Stevens-Johnson syndrome due to first-line antituberculosis drugs: a case report
- Volume 1982, No. 4 February 26, 1982
- Alopecia induced by tumour necrosis factor-alpha antagonists: description of 52 cases and disproportionality analysis in a nationwide pharmacovigilance database
- Non-hemorrhage-related adverse effects of rivaroxaban
- Alopecia Associated with Sulfasalazine
- Post-finasteride syndrome: newly recognised condition
- Finasteride
- Human papillomavirus vaccine recombinant bivalent
- Unraveling Ritlecitinib: an in-depth analysis of JAK3 inhibitor for the treatment of alopecia areata
- Sacituzumab Govitecan-Hziy (Trodelvy™)
- Enzyme‐Instructed Self‐Assembly for Cellular Supramolecular Chemistry
- The coudability sign of alopecia areata: the real story
- A guide to diagnosis and management of hypertrichosis
- Manifestaciones Cutáneas en el Paciente Inmunocomprometido: Una Revisión Narrativa
- Management of Cutaneous and Extracutaneous Side Effects of Smoothened Inhibitor Therapy for Advanced Basal Cell Carcinoma
- Clinical Pharmacokinetics and Pharmacodynamics of Finasteride
- ALOPECIA ANDROGENÉTICA: MINOXIDIL ORAL VERSUS OUTRAS TERAPIAS MEDICAMENTOSAS
- Winding the clock back on female androgenetic alopecia
- Alopecia areata induzida após síndrome DRESS com rápida resolução
- Phase I Clinical Testing Antimalarial Drugs.
- Efalizumab-induced hypertrichosis
- Enanthem in Patients With COVID-19 and Skin Rash
- Could Topical Minoxidil Cause Non-Arteritic Anterior Ischemic Optic Neuropathy?
- A case of eruptive lichen spinulosus after toxic epidermal necrolysis
- AN OVERVIEW OF SILVER NANOPARTICLES
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis
- Multiple sclerosis disease-modifying therapies: adverse effect surveillance and management
- Nanomedicine-based immunotherapy for tissue regeneration